melanoma TRP2 CTL epitope vaccine SCIB1

{
  "id": "MLC-T-ONC-015077",
  "term": "melanoma TRP2 CTL epitope vaccine SCIB1",
  "field": "Oncology and biomedicine",
  "definition": "A proprietary DNA-based cancer vaccine that encodes a melanoma antigen tyrosinase-related protein 2 (TRP2) cytotoxic T-lymphocyte (CTL) epitope and a modified monoclonal antibody, a chimera of human IgG1/murine IgG2a with T cell mimotopes expressed within the complementarity-determining regions (CDR) of the antibodies, with potential immunostimulating and antineoplastic activities. Upon intramuscular injection and electroporation, melanoma TRP2 CTL epitope vaccine SCIB1 expresses the modified antibody. Subsequently, the Fc component of the engineered antibody targets and binds to the CD64 receptor on the dendritic cells (DCs); upon processing by DCs, the cellular immune system may be activated to induce helper T-cell and CTL immune responses against tumor cells expressing the TRP2 antigen.",
  "synonyms": [
    "human IgG1/murine IgG2a double-expression vector encoding TRP2 CTL epitope vaccine SCIB1"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/melanoma-trp2-ctl-epitope-vaccine-scib1/"
}